Companies: 10,795·Total market cap: $144.5T
Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

RIGLNASDAQHealthcare● Active
$30.06
+$0.13(+0.43%)
Market Cap$556172525
P/E Ratio
52W High$52.24
52W Low$18.14
Overview

Rigel Pharmaceuticals, Inc. (RIGL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RIGL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$20.07rigl eps ttm · rigl earnings per shareEarnings history
PE Ratio (TTM)1.5×rigl pe ratio ttm · rigl price to earningsPE Ratio deep dive
Revenue (TTM)$299.8Mrigl revenue ttm · rigl annual revenueFull revenue history
Dividend YieldNo Dividenddoes rigl pay dividends · rigl dividend yieldDividend history
Shares Outstanding18.0Mrigl shares outstanding · rigl floatShares outstanding history
Next EarningsAug 4, 2026Est.rigl earnings date · rigl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$294.3M▲ +64.15% YoY
202320242025
rigel pharmaceuticals, inc. revenue · rigl revenue 2025
FY 2025Net Income$367.0M▲ +1999.08% YoY
202320242025
rigel pharmaceuticals, inc. net income · rigl profit 2025
FY 2025EPS$20.40▲ +1960.61% YoY
202320242025
rigl eps · rigel pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $299.8MNet Income: $364.2MEPS: $20.07View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis rigl a buy · rigl analyst rating
Strong Buy
0
Buy
8
Hold
7
Sell
0
Strong Sell
0
12-Month Price Target
$2.00Low
$30.06Current
$27.33Avg Target9.08% downside
$42.00High
rigl price target · rigl 12 month forecast

Total: 15 · Buy rate: 53.3%

The RIGL analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $27.33, representing -9.08% downside from the current price of $30.06.

Stock Performance

Full History
1D+0.55%
1W+0.55%
1M+15.57%
3M+4.24%
YTD-29.73%
1Y+37.73%
5Y-24.57%

About Rigel Pharmaceuticals, Inc.

CEORaul R. Rodriguez
IPO DateNov 29, 2000
Employees162
CountryUS
Websiterigel.com

Rigel Pharmaceuticals, Inc. a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an ora…

what is rigel pharmaceuticals, inc. · rigl stock overview · rigel pharmaceuticals, inc. company profile · who is rigel pharmaceuticals, inc. ceo · rigl NASDAQ · rigel pharmaceuticals, inc. headquarters · rigel pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Rigel Pharmaceuticals, Inc. (RIGL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 29, 2000. As of the latest trading session, RIGL stock price is $30.06, with a market capitalization of $556.2M. The stock has returned +37.73% over the past 12 months and -29.73% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Rigel Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $27.33. In fiscal year 2025, Rigel Pharmaceuticals, Inc. reported revenue of $294.3M and net income of $367.0M. For detailed data — including Rigel Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Rigel Pharmaceuticals, Inc. (RIGL) stock price is $30.06. The stock is traded on NASDAQ under the ticker symbol RIGL. The 52-week range is $18.14 – $52.24.

RIGL stock priceRIGL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice